Analystreport

Flexion Therapeutics Inc (NASDAQ: FLXN) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $24.00 price target on the stock.

Flexion Therapeutics, Inc.  (FLXN) 
Last flexion therapeutics, inc. earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.flexiontherapeutics.com